CareDx
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, CareDx sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
CareDx: 8 sponsored US clinical trials, none currently recruiting.
CareDx sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. The most-studied condition in this pipeline is Lung Transplant Failure and Rejection, with 1 trials.
Upper-quartile sponsor footprint
CareDx sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
AlloSure Lung Assessment and Metagenomics Outcomes Study
NCT05050955
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
NCT04635384
Molecular Assessment and Profiling of Liver Transplant Recipients
NCT04793360
Surveillance HeartCare® Outcomes Registry
NCT03695601
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
NCT05033548
Transition of Renal Patients Using AlloSure Into Community Kidney Care
NCT04601155
Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling
NCT02178943
How the CareDx archive is shaped
8 indexed studies, none listed as recruiting (0% open); 2 completed (25%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Lung Transplant Failure and Rejection (1 trial), 9 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
CareDx: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
CareDx sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this CareDx page
8 registered trials is a research-attention snapshot, not an endorsement of CareDx or any single study.
- None of CareDx's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Lung Transplant Failure and Rejection is the condition CareDx studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Lung Transplant Failure and Rejection trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
CareDx pipeline card: 8 registered trials from official public datasets.Report a data error.